Chinese Occupational Population Cohort of Lifestyle and Physical Fitness (LiFitChina)
LiFitChina
Effects of Lifestyle and Physical Fitness on Cardiovascular Health: a Cohort Study in Chinese Occupational Population
1 other identifier
observational
18,512
1 country
1
Brief Summary
The incidence and prevalence of metabolic risk factors such as obesity, hypertension, diabetes, and dyslipidemia, as well as cardiovascular diseases (CVD), are continuously rising among the occupational population in China, primarily comprising the middle-aged and young adults. Unhealthy lifestyles and declining physical fitness are independent risk factors affecting cardiovascular health. Additionally, the level of physical fitness is influenced by postnatal lifestyles. Lifestyle factors related to cardiovascular health in the occupational population encompass various aspects, including smoking, physical activity, diet, sleep, psychological stress, etc. These factors may interact or have a synergistic effect, necessitating a comprehensive assessment. This project proposes a prospective cohort study design to establish a monitoring cohort for lifestyle and physical fitness among the occupational population. The study will track and follow individuals with or without any CVD metabolic risk factors, collecting information on general status, lifestyle, physical fitness, and health examination data. Exposure factors such as lifestyle and physical fitness will be measured annually, and the occurrence of CVD-related health outcomes will be observed. The aim is to develop a comprehensive evaluation index for cardiovascular health lifestyle, analyze the direct and indirect impacts of lifestyle and physical fitness on the occurrence and development of CVD, and explore potential mediating and moderating effects of physical fitness in the association between lifestyle and cardiovascular health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 11, 2023
CompletedFirst Submitted
Initial submission to the registry
February 17, 2024
CompletedFirst Posted
Study publicly available on registry
February 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 11, 2026
February 28, 2024
February 1, 2024
3 years
February 17, 2024
February 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the composite end point of new major adverse cardiovascular events
including cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, coronary revascularization and unstable angina pectoris requiring hospitalization
10 years
Secondary Outcomes (9)
new incidence of each major adverse cardiovascular events
10 years
new incidence of cancer
10 years
new incidence of all-cause death
10 years
level of systolic pressure
10 years
level of diastolic pressure
10 years
- +4 more secondary outcomes
Eligibility Criteria
occupational person free of cardiovascular disease at baseline in China
You may qualify if:
- adults between 18-59 years of age
- occupational staff
- willing to accept long-term follow-up
You may not qualify if:
- participants with previous CVD history such as myocardial infarction, stroke and severe aortic stenosis;
- with cancer;
- with congenital genetic diseases, or cannot cooperate with the investigation and follow-up due to acquired diseases, such as congenital heart disease, paralysis, deafness, dementia, mental abnormality, developmental retardation, etc.;
- with exercise contraindications;
- duration of pregnancy;
- refuse to sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2024
First Posted
February 23, 2024
Study Start
December 11, 2023
Primary Completion (Estimated)
December 11, 2026
Study Completion (Estimated)
December 11, 2026
Last Updated
February 28, 2024
Record last verified: 2024-02